National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 1 of 2001)

Administered by Department of Health, Disability and Ageing

Legislation au F2007B01031 Not in force Legislative Instrument

Legislation content

 

 

 

 

COMMONWEALTH OF AUSTRALIA

National Health Act 1953

PHARMACEUTICAL BENEFITS

DECLARATION UNDER SUBSECTION 85 (2AA)

No. PB 1 of 2001

 

 

 

I, ALAN WILLIAM STEVENS, Acting Assistant Secretary, Pharmaceutical Benefits Branch, Department of Health and Aged Care and Delegate of the Minister for Health and Aged Care, having in accordance with subsection 85 (2AB) of the National Health Act 1953 obtained the advice of the Pharmaceutical Benefits Advisory Committee, pursuant to subsection 85 (2AA) of the National Health Act 1953, hereby make the following Declaration:

 

  1. This Declaration commences on 1 February 2001.

 

2.                   The drugs and medicinal preparations specified in the Schedule to this Declaration shall cease to be drugs and medicinal preparations to which Part VII of the National Health Act 1953 applies.

 

THE SCHEDULE

 

Desipramine Hydrochloride

Ferrous Sulfate – Dried

Medrysone

Prednisolone Acetate

 

 

Dated this 4th day of January 2001.

 

 

 

 

 

 

ALAN WILLIAM STEVENS

Acting Assistant Secretary

Pharmaceutical Benefits Branch

Department of Health and Aged Care

Delegate of the Minister for Health and Aged Care

 

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.